Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pippenger, M.
Right arrow Articles by Vickrey, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pippenger, M.
Right arrow Articles by Vickrey, B. G.
Neurology 2001;56:1206-1209
© 2001 American Academy of Neurology
Brief Communications

Neurologists’ use of ICD-9CM codes for dementia

Mark Pippenger, MD;, Robert G. Holloway, MD, MPH; and Barbara G. Vickrey, MD, MPH

From the Department of Neurology (Drs. Pippenger and Vickrey), University of California, Los Angeles, and the UCLA Alzheimer’s Disease Research Center of California, Los Angeles; and the Department of Neurology (Dr. Holloway), University of Rochester School of Medicine and Dentistry, Rochester, NY.

Address correspondence and reprint requests to Dr. Mark Pippenger, UCLA Department of Neurology, C-128 RNRC, Box 951769, Los Angeles, CA 90095-1769; e-mail: mpippeng{at}ucla.edu

Neurologists’ use of ICD-9CM codes in a sample of 181 consecutive, new patients evaluated for dementia by 48 of all 49 neurologists from the Rochester, NY, area over a 1-year period was examined. The specific code for AD, 331.0, was used for only 36.5% of patients judged by the neurologist to have AD as the most likely diagnosis. Other codes used were not inaccurate but would result in lower reimbursement. Variation in coding could affect validity of dementia research using claims data.




This article has been cited by other articles:


Home page
 NeurologyHome page
H. Fillit, G. Hess, J. Hill, P. Bonnet, and C. Toso
IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
Neurology, July 21, 2009; 73(3): 180 - 185.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
B. G. Vickrey, B. S. Mittman, K. I. Connor, M. L. Pearson, R. D. Della Penna, T. G. Ganiats, R. W. DeMonte Jr., J. Chodosh, X. Cui, S. Vassar, et al.
The Effect of a Disease Management Intervention on Quality and Outcomes of Dementia Care: A Randomized, Controlled Trial.
Ann Intern Med, November 21, 2006; 145(10): 713 - 726.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. J. Foley, D. B. Brock, and D. J. Lanska
Trends in dementia mortality from two National Mortality Followback Surveys
Neurology, February 25, 2003; 60(4): 709 - 711.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.